64
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Phase I Study of Arabinosyl-5-zacytidine (Fazarabine) in Adult Acute Leukemia and Chronic Myelogenous Leukemia in Blastic Phase

, , , , , , & show all
Pages 511-518 | Received 30 Dec 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tadeusz Robak & Agata Wrzesień-Kuś. (2002) The Search for Optimal Treatment in Relapsed and Refractory Acute Myeloid Leukemia. Leukemia & Lymphoma 43:2, pages 281-291.
Read now

Articles from other publishers (18)

Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism 107 142 .
Khushboo Agrawal, Viswanath Das, Pankhuri Vyas & Marián Hajdúch. (2018) Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic. Pharmacology & Therapeutics 188, pages 45-79.
Crossref
Björn Tampe & Michael Zeisberg. (2018) Chromatin dynamics at the core of kidney fibrosis. Matrix Biology 68-69, pages 194-229.
Crossref
Edurne San Jose-Eneriz, Xabier Agirre, Paula Rodríguez-Otero & Felipe Prosper. (2013) Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia. Epigenomics 5:5, pages 525-538.
Crossref
Bastian Scholz & Rolf Marschalek. (2012) Epigenetics and blood disorders. British Journal of Haematology 158:3, pages 307-322.
Crossref
Bart Claes, Bernard Siebens & Diether Lambrechts. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Marcela KrečmerováMiroslav Otmar. (2012) 5-azacytosine compounds in medicinal chemistry: current stage and future perspectives. Future Medicinal Chemistry 4:8, pages 991-1005.
Crossref
Sonia Mulero-Navarro & Manel Esteller. (2008) Epigenetic biomarkers for human cancer: The time is now. Critical Reviews in Oncology/Hematology 68:1, pages 1-11.
Crossref
Jörg Dietrich & Patrick Y. Wen. 2008. Cancer Neurology In Clinical Practice. Cancer Neurology In Clinical Practice 287 326 .
Marcela Krečmerová, Antonín Holý, Alois Pískala, Milena Masojídková, Graciela Andrei, Lieve Naesens, Johan Neyts, Jan Balzarini, Erik De Clercq & Robert Snoeck. (2007) Antiviral Activity of Triazine Analogues of 1-( S )-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine (Cidofovir) and Related Compounds . Journal of Medicinal Chemistry 50:5, pages 1069-1077.
Crossref
Michael A. Morgan & Christoph W. M. Reuter. (2006) Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias. Annals of Hematology 85:3, pages 139-163.
Crossref
Takashi Kumagai, Ayalew Tefferi, Letetia Jones & H. Phillip Koeffler. (2005) Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia. Leukemia Research 29:5, pages 511-515.
Crossref
Curtis Balch, Tim H.-M. Huang, Robert Brown & Kenneth P. Nephew. (2004) The epigenetics of ovarian cancer drug resistance and resensitization. American Journal of Obstetrics and Gynecology 191:5, pages 1552-1572.
Crossref
I. Cvetkovic, D. Popadic, O. Vuckovic, Lj. Harhaji, Dj. Miljkovic & V. Trajkovic. (2004) 5-Aza-2′-deoxycytidine stimulates inducible nitric oxide synthase induction in C6 astrocytoma cells. Brain Research 998:1, pages 83-90.
Crossref
Giuseppe Leone, Maria Teresa Voso, Luciana Teofili & Michael Lübbert. (2003) Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. Clinical Immunology 109:1, pages 89-102.
Crossref
J. Goffin & E. Eisenhauer. (2002) DNA methyltransferase inhibitors—state of the art. Annals of Oncology 13:11, pages 1699-1716.
Crossref
Jen C. Wang, Wilson Chen, Selvarany Nallusamy, Chi Chen & Allan D. Novetsky. (2002) Hypermethylation of the P15 INK4b and P16 INK4a in agnogenic myeloid metaplasia (AMM) and AMM in leukaemic transformation . British Journal of Haematology 116:3, pages 582-586.
Crossref
Francis J. GilesGuillermo Garcia-ManeroJorge E. CortesSharyn D. BakerCarol B. MillerSusan M. O'BrienDeborah A. ThomasMichael AndreeffCarol BivinsJacques JolivetHagop M. Kantarjian. (2002) Phase II Study of Troxacitabine, a Novel Dioxolane Nucleoside Analog, in Patients With Refractory Leukemia. Journal of Clinical Oncology 20:3, pages 656-664.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.